Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2026-01-01 @ 10:38 AM
Study NCT ID:
NCT05121103
Status:
TERMINATED
Last Update Posted:
2025-06-22
First Post:
2021-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor:
Epizyme, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-18
First Submit QC Date:
None
Study First Post Date:
2021-11-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-25
Results First Submit QC Date:
None
Results First Post Date:
2025-05-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-19
Last Update Post Date:
2025-06-22
Last Update Post Date Type:
ACTUAL